Grants
Grants listed represent those for which Johns Hopkins Infectious Diseases researchers are principal investigators.
Displaying 1 - 10 of 38 results
-
A Multicenter, Randomized, Double-Blind, Placebo controlled Study to Assess the Efficacy and Safety of Treatment with Bepirovirsen in Participants living with Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection on Antiretroviral Treatment
Research Grant Start Date:
12/01/2024Research Topics:
Research Lead Investigators:
-
Dissecting Hepatitis B Vaccine Adjuvant Effects on Immune Responses and the HIV Reservoir in PLWH
Research Grant Start Date:
07/25/2024Research Topics:
Research Lead Investigators:
-
Point-of-care magnetofluidic HCV diagnostic using thermally responsive valves
Research Grant Start Date:
12/01/2023Research Topics:
Research Lead Investigators:
-
IHBEM: Modeling the influence of individual and network behavior on HIV/HCV transmission dynamics
Research Grant Start Date:
09/15/2023Research Locations:
Research Topics:
Research Lead Investigators:
-
Mechanisms of HBV cccDNA transcriptional regulation in persons with and without HIV
Research Grant Start Date:
08/07/2023Research Topics:
Research Lead Investigators:
-
Leveraging the plasma virome as a biological indicator of HIV risk and transmission networks among people who inject drugs
Research Grant Start Date:
06/01/2023Research Topics:
Research Lead Investigators:
-
Molecular and structural characterization of broadly neutralizing anti-HCV antibodies
Research Grant Start Date:
02/15/2023Research Topics:
Research Lead Investigators:
-
The role of neutralizing antibodies in natural and treatment-induced control of hepatitis B with and without HIV-1 co-infection
Research Grant Start Date:
01/24/2023Research Locations:
Research Topics:
Research Lead Investigators:
-
A Phase 2 Study to Evaluate the Safety, Tolerability, and Efficacy of Regimens Containing VIR-2218, VIR-3434, and/or PEG-IFNa in Subjects with Chronic Hepatitis B Virus Infection
Research Grant Start Date:
12/02/2022Research Topics:
Research Lead Investigators:
-
Phase 3 Multicenter, Randomized, Double-Blind, Study to Assess the Efficacy and Safety of Treatment with Bepirovirsen in HBeAg-negative Nucleos(t)ide Analogue-treated Participants with Chronic Hepatit
Research Grant Start Date:
12/01/2022Research Topics:
Research Lead Investigators: